04 September 2011

4 Sept: IPO -Brooks, SRS, TD Power, NCD Manappuram Finance, Muthoot Finance GMP; Gray Market Preimum

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Company Name
Offer Price (Rs)
Expected Listing Price Premium



Vaswani Ind.
52
Discount
Brooks Lab.
100
5 to 6
SRS Ltd.
58
 1 to 2
T. D. Power Systems
256
Discount
Manappuram Finance
1000
Discount
Muthoot Finance
1000
0.5%


IIFL 1-Month Portfolio: Bets for September

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

Click on company name (link) below for details on company


Godrej Consumer – BUY


Hindustan Zinc – BUY



Jain Irrigation – BUY


Mahindra & Mahindra – BUY



Sun Pharma – BUY

Long Nifty Put


Click on company name (link) above for details on company

Market Outlook
Global stock markets have come back smartly over the past few
sessions from their yearly lows after being on a slippery slope for
quite a while. Federal Reserve Chairman Bernanke's recent remarks
suggest that the US central bank is confident of growth picking up
later this year. Not only that, the FOMC meet in September has been
extended to two days to take stock of the current conditions and
frame an appropriate policy response. Back home, the Parliament’s
unanimous resolution on the Lokpal issue after a constructive
discussion has fuelled expectations that a few key reform bills may
get cleared soon. Meanwhile, India's economic growth eased to 7.7%
yoy in the April to June quarter.
For September, we expect more volatility amid persistent
uncertainty surrounding the domestic as well as overseas macroeconomic
conditions. Although the markets have retraced from
recent lows, the sustainability of the advance is in doubt. At the
same time, markets can rise further if the RBI signals an end to its
monetary tightening cycle on Sept. 16. Pick up in monsoon, a trend
reversal in the FII flows and positive announcements on the policy
front could also add to the buoyancy.
Portfolio Brief
This month we recommend four fresh stocks Godrej Consumer, HZL,
M&M and Sun Pharma while retaining Jain Irrigation. Considering
that the domestic indices have corrected sharply, we have reduced
the cash level in our portfolio, while maintaining a hedge to the
portfolio against a steep correction.
Previous month portfolio performance
Our August month portfolio delivered a weighted average profit of
3.9%, outperforming the benchmark Nifty by 1,270bps. The positive
return was large due to the hedge taken for the portfolio.
Note: Executable size of the portfolio is ~Rs133,333 (minimum) and in multiples thereof.
It has been mentioned to facilitate precise investment allocation and return calculation

Indian stocks take a break from the Dow ::Business Line,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Fundamentals in the Indian market may have to look up for Indian equities to stage a turnaround.
It was a stormy relationship until it broke up. The Indian stock market has always stayed faithful to gyrations in US equities — we saw it in the bull market to 2007 and then during the 2008 meltdown. But recent trends suggest that this relationship may now be weakening.
Between November 2010 and July 2011, while the Sensex dropped by 11 per cent, the US bellwether Dow Jones Industrial Average actually took the opposite direction, creeping up by 9 per cent.
That is what is captured in the ‘correlation' (a measure of how much one index is influenced by changes in another) between the Indian and US stock markets moving to a negative 0.6 in this phase, after staying at a positive 0.8 for most of the last five years. We used the MSCI indices to run a correlation analysis between India and other key global markets.
Now, the crucial question is: Will Indian markets recover when the US picks up again or will it continue its downtrend in isolation? To answer this, we may first need to look at why the Indian market may have behaved differently from others in the November-July period.

RALLY IN COMMODITIES

Following the unrest in the MENA (Middle-East and North Africa) region which led to fears of supply disruption in oil, crude oil price rallied 31 per cent in the November 2010-July 2011 period.
India has the least to gain from rising oil and commodity prices among the BRIC nations. The country imports close to 75 per cent of its crude oil requirements and has more commodity users in its key indices than mining or commodity companies.
The crude oil price rally fired other commodities too. The Reuters CRB Commodity index, which is based on future price of 19 commodities, rallied 13 per cent in the November 2010-July 2011 period. With prices of input commodities rising, investors got wary about Indian equities. The caution was understandable. Between March 2007 and September 2008, when commodities entered bubble territory, BSE-500 companies saw their profit margins drop by six percentage points and net profit fall 27 per cent.
Rising commodity prices saw investors abandoning Chinese stocks too. The Shanghai Composite index was down by 12 per cent (at par with Indian markets) in the November-July period. However, investors bullish on commodities did a portfolio rejig in favour of other BRICs, reports EPFR Global, a research house that tracks global fund flows.
With Russia holding the world's largest oil reserves next to Middle East and Africa, the Russian equities market saw good inflows in this period.

HIGH INFLATION AND INTEREST RATE

With rising energy and commodity prices, food inflation also escalated in India between November and July. Even as the Consumer Price Index averaged a 9 per cent increase in this period, food inflation measured by the Wholesale Price Index touched 20 per cent in the last week of December 2010.
To counter rising inflation, the Reserve Bank of India (RBI) began raising key policy rates. Between November 2010 and July ‘11, interest rates were raised six times, with the repo rate rising 200 basis points to 8 per cent in this period (in the last interest up-cycle in 2008, the repo rate hit a high of 9 per cent).
The end to India's easy money policy even as markets such as the US retained rates at historic lows, stoked fears of rising borrowing costs hurting growth for domestic industry.
This was reflected in the Index of Industrial Production (IIP) weakening from the beginning of 2011. In the March 2011 quarter IIP growth fell to 7.8 per cent versus 14 per cent in the same period of 2010; in the June quarter the growth was 7 per cent versus 10 per cent in the June 2010 quarter.
Interest rate risks were also seen to be high for Brazil, and its stock market was beaten down by 18 per cent in the November-July period.

LOWER EARNINGS

Attribute it to higher input costs or slowly rising interest rates, India Inc's quarterly report card began to lose sheen from the December quarter of 2010.
Earnings slowed from an annual growth of 21 per cent in the December-2010 quarter to 13 per cent in the March-2011 quarter and a modest 5 per cent in the June-2011 quarter for the BSE-500 companies.
Profit margin at the operating level was down three percentage points (to 25 per cent) in the June 2011 quarter compared to the December-2010 quarter. In the previous commodity rally in 2007-2008, operating profit margins touched a low of 23 per cent for the same set of companies.

GOVERNANCE ISSUES IN CORPORATE INDIA

The chain of arrests that followed the housing loan scam and the 2G spectrum investigations did their bit to create doubts in the minds of foreign investors and resulted in the abrupt de-rating of stocks across sectors such as telecom, realty and banks.
Though the issues were specific to companies, it left a larger impact.Business Line's analysis also found that foreign institutional investors exited the controversial stocks in large numbers between December 2010 and March 2011.
FII holdings in Unitech and DB Realty dropped from 34.6 per cent and 7.7 per cent in end-September 2010 to 31.7 and 5.5 per cent, respectively in March 2011. The political environment too has not been conducive, with the many allegations of corruption against the ruling coalition.

CURRENCY- NO INCENTIVE

A strong rupee has always been an attraction for global investors to invest in India, as it bolsters their investment returns. But the rupee has stayed flat for much of the November-July period, at about Rs 44 against the dollar.
In the 2007 rally, the currency equation was favourable to India.
That year, the INR appreciated 11 per cent against the dollar and closed the year at 39.4. SEBI reported a net inflow of Rs 71,487 crore from foreign institutional investors for 2007.

PRE-CONDITIONS FOR INDIA RECOVERY

From the above, the following may be the two necessary conditions for a stock market recovery in India:
A cooling off of commodity prices, particularly that of crude oil.
A pause in the RBI's rate hike cycle. Though the lag effect of recent hikes may continue to be felt for some time, an end to rate hikes will have investors taking a more positive view of next year's earnings.
In PE (price-earnings) terms, the Sensex trades at a price-earnings multiple of 14 times estimated 2011-12 earnings. This is still at a premium to the Emerging Markets pack (China's Shanghai Composite at 11 times, South Korea's KOSPI at 8.5 times and Taiwan's TAIEX at 12.7 times) or the US (Dow Jones at 10.7 times) itself.
India's (Sensex) earnings growth for FY12 is estimated at 7 per cent against 18.4 per cent growth for China (Shanghai Composite) and 15.5 per cent growth for the US (Dow Jones)

Are emerging markets decoupling for real?:: Business Line,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


The US stock market still wields a fairly big influence on the equity markets around the world. But what is interesting is that even as developed markets have moved in step with the US, the emerging markets pack seems to be gradually shaking off the US influence and charting a path of its own.
The correlation between the MSCI US and MSCI EM index (consisting of 21 emerging market country indices including Brazil, China, Egypt, India, Indonesia, Korea, Malaysia, Russia, Taiwan, and Thailand), which was strong at 0.97 in 2008 and 2009, dropped to 0.86 in 2010.
Even as the EM index recorded 16 per cent returns in the year, the US index registered a return of 13 per cent only. Mulling the numbers of recent months, we find that the link between the US and EMs have weakened further.
In the November 2010-July 2011 period correlation between the MSCI US and MSCI EM index came down to 0.5. This suggests that the two indices didn't move in tandem very often.
The ‘decoupling' of the EMs from the developed world has been talked about for a long time now, given that the economic prospects of these markets have remained good even amidst the turmoil in the developed world. Even as EM countries looked a relatively better bet compared to developed markets in 2010 on their valuation and earnings prospects, it was the commodity price rally that changed the picture.
Rising inflation and spiralling interest rates specific to these countries have had investors pulling out of EMs.
However, the weakening correlation between EMs and the developed markets suggests that global investors may at last be beginning to analyse EMs on their own merits or demerits.
If commodity prices cool off with slowing growth in the developed world, inflation fears may recede. That may lure global investors back to the EMs once again.

Long Nifty Put:: IIFL 1-Month Portfolio: Bets for September

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


To hedge our portfolio against sharp correction in the markets due to uncertainty in the global
markets, we recommend investors to buy September 4900 Put at ~Rs80. The Maximum Loss would be
Rs4,000/lot with Break even Nifty Level at 4820 on downside beyond which the Strategy has a positive
pay-off.


Long/ Short Long
Option Type Put
Expiry Sep-11
Strike Price 4900
Premium (Rs) 80
IV 22
Quantity 50


Sun Pharma – BUY:: IIFL 1-Month Portfolio: Bets for September

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Preeminent play in pharma space
Sun Pharma has one of the fastest growing and most resilient
businesses among Indian generics players. The company has
historically focused on the domestic and US markets, but lately it has
started generating significant revenues in other geographies as well
(International market constituted 60% of FY11 sales). The company
has consistently delivered growth and has proven its expertise in
driving operational efficiencies to extract margins that are
significantly higher than competitors (~34% v/s industry margin of
~22%)
One of the best franchises in domestic market
Company’s domestic business comprises mainly of high margin and
high growth therapeutic areas like CVs, Neurology and diabetology
(chronic segment). The brand franchise of the drugs in chronic
segments, once established, is durable. Industry surveys indicate
high level of brand recognition for Sun Pharma’s products among
doctors. Sun Pharma’s prudent brand building strategy is evident
from its top 10 selling brands that constitute 15% of domestic sales.
Sun Pharma’s 2,700-strong field force has ensured wide market
reach and largest market share (~4.4%) in highly fragmented
domestic pharma market.
US business to flourish with Taro in bag
After a two-year legal tussle, Sun Pharma acquired majority control
of Taro Pharma in the US. Taro’s acquisition has strengthened the
portfolio of the company in US market. However, in the short term,
it would act as a headwind to the margins of the company (though in
Q1FY12 Taro reported better than expected margin; 35% v/s
expected 27%). Sun pharma as a whole as on June 2011 has ANDAs
for 151 products pending for approval (including 19 tentative
approvals).
Steady growth ahead; Leveraging through Partnership
We believe the worst of Sun Pharma’s troubles regarding its
acquisition of Taro are over, and the company is now set to show
steady growth in the US base business. Sun Pharma and Merck JV
for EMs excluding India will pay off FY14 onwards. We expect
24%/26% Revenue/PAT CAGR respectively over FY11-FY13E.
Healthy Balance Sheet (US$1bn cash) and superior return ratios
makes Sun Pharma as one of the best bet in pharma space.

Mahindra & Mahindra – BUY:: IIFL 1-Month Portfolio: Bets for September

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Strong demand for tractors to continue
Following a 19% CAGR during FY03-07, tractor volumes in India
went through a sedate phase during FY08 and FY09 with volumes
remaining flat at 0.35mn tractors per annum. However, in FY10 and
FY11 the volume growth jumped to 27% and 25% respectively. The
factors that caused this change were 1) farm loan waiver scheme
worth Rs653bn benefiting about 36mn farmers, 2) raising of MSP for
crops, 3) RBI asking banks to increase lending to rural areas, 4)
employment guarantee scheme, 5) increasing non-agriculture usage
of tractors. The effect of these factors will continue to last over the
next couple of years causing the demand to grow in the range of 13-
15%. M&M with ~43% market share would be a major beneficiary.
Leadership position in UVs to be maintained
M&M is by far the leading player in the Indian UV industry with a
53% market share. With the next two largest players accounting for
33% of the market share, the competition is limited at price points
where M&M operates. With substantial portion of demand for UVs
arising from rural areas and M&M’s strong brand recall, UV volume
growth would remain strong for the company.
Ssangyong performance to improve going ahead
During Q2 CY11, Ssanyong sold 30,772 vehicles, highest since Q2
CY07. This trend is expected to continue considering M&M’s expertise
in the UV markets. Financial performance in Q2 CY11, however, was
plagued by higher wage costs and price hikes given to vendors.
Given M&M’s track record of cutting costs and expectations of
continued volume momentum, we expect Ssangyong to report
improved operating performance in the medium term.
Re-rating on the cards
M&M has historically been trading at a substantial discount to its
domestic peers owing to cyclicality of tractor business, exposure to
multiple business streams and losses at few of its subsidiaries. With
expected improvement in subsidiary performance and strong growth
in automotive and tractor volumes, a re-rating cannot be ruled out.

Jain Irrigation – BUY:: IIFL 1-Month Portfolio: Bets for September

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Key beneficiary of micro-irrigation (MIS) potential
MIS holds tremendous potential as out of the total 140mn hectares
of arable land, only about 50% is rain-fed. Government has also
accorded significant priority to micro-irrigation schemes (increase in
subsidy to 60% from 40% for small farmers and marginal farmers
and 50% for farmers with up to 5 hectares of holding) as part of its
reforms in agriculture output. With only 4mn hectares covered under
drip irrigation and sprinklers, we believe despite the strong growth
over the past few years, we think a considerable opportunity still lies
ahead. Jain Irrigation, a dominant player with 55% share, derives
nearly half of its revenues from micro-irrigation and is likely to be a
key beneficiary of the inherent micro-irrigation potential; we factor
in a robust 30% growth in MIS in FY12.
New pipe sub-segments to drive growth
Jain Irrigation has traditionally operated in the PVC pipes business
(~19% of FY11 revenues) used for sanitation, rain-water harvesting
and electrical insulation. We expect strong demand to continue on
the back of various government-led infrastructure initiatives for safe
drinking water, rural/urban sanitation and water conservation.
Additionally, the company now offers different applications for pipes,
ranging from those used in city gas distribution networks, sewage &
waste disposal and telecom cables. Although telecom demand may
be muted, increased demand from city gas distribution companies
would drive growth in this sub-segment.
Expect 20% growth in agro-processing biz in FY12
Agro processing (onion & mango processing), hitherto a small part of
revenues, has gained size post a slew of organic and inorganic
initiatives and now forms ~15% of topline with focus on overseas
markets. We factor in a healthy 20% growth in agro-processing
revenues in current fiscal while a fall in onion prices could aid margin
in the onion-dehydration business.
Valuations appear attractive; recommend BUY
We expect MIS to deliver strong performance aided by various
initiatives from the central government; management has guided for
30% yoy growth in micro-irrigation in the current year. Further,
subdued polyethylene prices could translate into higher EBITDA
margins. Valuations appear attractive at 18x FY13 PE.

Hindustan Zinc – BUY:: IIFL 1-Month Portfolio: Bets for September

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Metal prices downside limited
We believe downside for metal prices from the current levels would
be limited driven by a tight concentrate market and robust demand
from the galvanizing industry. Rising energy costs would further
provide support on the downside and would help stabilize metal
prices. Zinc demand-supply surplus of 0.21mn tons for 2010 was
quite lower than ILZSG’s earlier expectation of 0.42mn tons. We
expect the surplus to shrink further in 2011 and would be lower than
the 0.19mn tons estimated by the organization. We estimate
average zinc prices of US$2,250/ton in FY12 and FY13.
Metal production to surge 25% over FY11-13E
HZL’s expansion to 1mtpa was completed with the commissioning of
the lead smelter in Q1 FY12. We expect zinc utilization rate to
increase to 90% in FY12 from 80% in FY11, as issues with
availability of water to the smelters has eased off. This coupled with
the commissioning of the lead smelter will push volumes higher by
50% over FY10-13E. The company is also ahead of its expansion
plan at its Sindesar Khurd mine. Sindesar mine has a much higher
silver content (c188ppm over life of mines) and would lead to a jump
in the company’s silver production.
Higher by-product revenue to offset rising costs
We believe over the next two years HZL’s cost is bound to increase
due to higher strip ratios at some mines and rising coal costs. This
impact would be negated by a steady by-product prices and jump in
silver production. We expect silver volumes of 315 tons in FY12 and
443 tons in FY13, adding Rs15bn in FY12 and Rs22bn in FY13 to the
company’s topline. With silver being a by- product, it adds little to
costs and most of the revenue flows directly to the bottom line.
Valuations attractive; Recommend BUY
We expect HZL to witness earnings CAGR of 18.4% over FY10-13E
largely driven by higher zinc, lead and silver volumes along with firm
realisations. We believe strong cash flow generation over the next
two years would further fortify HZL’s balance sheet. Cash balance is
expected to increase from 157bn (30% of current market cap) at the
end of Q1 FY12 to 252bn by FY13E. At the CMP of Rs130, the stock
is trading attractively at 3.8x FY13E EV/EBIDTA and is lower than its
international peers. We recommend a BUY rating on the stock.

Godrej Consumer – BUY:: IIFL 1-Month Portfolio: Bets for September

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Getting aggressive in innovations
GCPL has become aggressive in innovations across its key markets,
resulting in a strong ~40% yoy growth in revenues during Q1 FY12
at Rs10bn. The higher adspend on account of increase in new
launches will put pressure on operating margin in the near term.
However, the aggressive innovation strategy will help the company
in the long run. The management has charted a rapid growth plan
and targets to achieve revenue CAGR of 26% over the next 10
years. Around 10% growth is envisaged through the inorganic route.
All this translates into increasing revenues 10x by 2021.
Strong growth momentum across segments
Both the domestic and international businesses of GCPL are
witnessing a strong revenue growth momentum. Home insecticides
business recorded a 40% yoy growth (>2x category growth) while
soaps revenues grew by 17% yoy - ahead of the industry growth of
8-9% during Q1 FY12. On the international business front, GCPL’s
older international business surpassed expectations with hair colours
in South Africa recording 19% yoy growth and UK growing by 16%
yoy. GCPL has started launching new products in its recently
acquired businesses which will further drive growth.
Management targets cost synergies of Rs2bn per year by FY15
GCPL is looking at cost synergies of Rs2bn per year by FY15 from the
merger of GCPL and GHPL. The savings are expected to come from
cost reduction following the merger of sales and marketing functions,
benefits of scale in media and raw material buying and operating
leverage from higher turnover generated due to distribution
synergies. Some of the synergies like cost reduction and scale
benefits would fully flow through in FY12.
Earnings to witness 22% CAGR, recommend Buy
GCPL is actively scouting for acquisitions in the domestic and
international market (especially in Africa/ Latin America) provided
there is a strong strategic and operational fit and the transaction is
EVA positive in the first year. GCPL’s successful acquisition
integration in the past makes us confident of the management’s
ability to derive synergy benefits. Acquisition, if any, could be a
major growth driver. At the current market price of Rs427, the stock
is trading 17.9x FY13E EPS of Rs23.9. We recommend Buy.

Weekly Review Report - September 04, 2011 :Angel Broking

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Finally the awaited bounce has come - Sustainability in Jeopardy
Sensex (16821) / Nifty (5040)
We had mentioned in our previous Weekly report that the
momentum oscillator viz., the "RSI - Smoothened" is placed well
in the oversold territory. Therefore, we had advised to avoid
fresh short positions as the bounce was expected due to oversold
condition of the oscillator. Also, we had stated that indices may
test 16550 - 16750 / 4966 - 5050 levels if they manage to
sustain above 16256 / 4888 level. The week opened on an
optimistic note in - line with global cues and traded with positive
bias throughout the week to give a close well above 5000 mark.
The Sensex ended with a mammoth gain of 6.14%, whereas
the Nifty gained 6.15% vis-à-vis the previous week.
Pattern Formation
􀂄 The Weekly chart depicts a positive crossover in "RSI"
momentum oscillator.
􀂄 The "20 EMA" on the Daily chart is placed at 16825 / 5052
level.
Future Outlook
Our benchmark indices opened with a decent upside gap on
Monday's session and continued to surge higher to give a close
well above 5000 mark. As expected, the "RSI - Smoothened"
turned upwards from its oversold territory and gave a positive
crossover on Monday's session which led indices to give
enormous bounce of 6% in spite of truncated week. We are
now observing that indices have closed marginally below
"20 EMA" on Friday's session which is placed at 16825 / 5052
level. Generally, the "20 EMA" is considered as a decent
support / resistance. Therefore, going forward, indices may
face some resistance near 16825 / 5052 level on a closing

basis. On the positive front, the "RSI" momentum oscillator on
the Weekly chart has given a positive crossover which indicates
a possibility of a further bounce if indices manage to sustain
above Friday's high of 16990 / 5114. In this case, they are
likely to rally towards17100 - 17250 / 5150 - 5200 levels. On
the downside, if indices breaks 16688 / 4993 then they are
likely to drift towards 16250 - 16550 / 4950 - 4870 levels.
Therefore, we advise our traders to stick to a stock centric
approach and avoid heavy trading on a positional basis.

Report on GDP (April-June, 2011) by IDFC Securities

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Key takeaways

We expect strong momentum in services and pick up in investment spends, as clarity emerges on the interest rate front, to drive growth in FY12. We maintain our GDP estimate for FY12 at 7.8% yoy.    

GDP growth for Q1FY12 came in at 7.7% yoy, in line with market expectations. Strong growth in manufacturing segment (7.2% yoy) and services (10% yoy) lead the overall growth momentum. Agricultural growth moderated to 3.9% yoy on account of a higher base. While private consumption remained healthy at 6.3% yoy, growth in gross fixed capital formation (GFCF) surprised positively at 7.9% yoy. Overall, while GDP growth has moderated to 7.7% yoy in Q1FY12 from 8.8% yoy in Q1FY11, the extent of moderation has been lower than anticipated. Further, data revisions have also buffered growth moderation to an extent. Going ahead, we expect strong momentum in services and pick up in investment spends, as clarity emerges on the interest rate front, to drive growth in FY12. We maintain our GDP estimate for FY12 at 7.8% yoy.    
 
 
Real (% yoy)
Nominal (% yoy)
 
Q1FY11
Q4FY11
Q1FY12
Q1FY11
Q4FY11
Q1FY12
Agriculture, forestry & fishing
2.4
7.5
3.9
26.3
25.6
16.7
Mining & quarrying
7.4
1.7
1.8
26.9
19.1
14.4
Manufacturing
10.6
5.5
7.2
18.3
11.3
13.8
Electricity, gas & water supply
5.5
7.8
7.9
12.7
11.6
8.2
Construction
7.7
8.2
1.2
19.0
17.6
10.7
Industry
9.1
6.1
5.1
19.0
15.0
12.6
Trade, hotels, transport & commn.
12.1
9.3
12.8
20.4
14.1
20.5
Financing, insurance, real estate & business services
9.8
9.0
9.1
21.2
18.8
19.1
Community, social & personal services
8.2
7.0
5.6
21.1
16.7
15.3
Services
10.4
8.0
10.0
20.8
15.4
18.8
GDP at factor cost
8.8
7.4
7.7
21.3
17.1
16.7
Private Final Consumption Expenditure
9.5
8.0
6.3
21.2
17.0
16.3
Government Final Consumption Expenditure
6.7
4.9
2.1
20.7
14.6
11.3
Gross Fixed Capital Formation
11.1
0.4
7.9
18.5
7.1
14.2
Exports
9.8
25.0
24.3
23.3
37.1
35.2
Less Imports
15.2
10.3
23.6
27.2
21.1
32.9
GDP at market prices
9.1
7.7
8.5
22.1
17.9
17.5
 
 
 
 
 
IDFC Securities Research